Anticoagulation/Thromboembolism
RSSArticles
-
Treatment of Hypertension: Does Choice of Drug Therapy Make a Difference?
-
Troponin and Exercise Testing
-
Hot Plaques in Acute Coronary Syndromes?
-
Sudden Death After Radiofrequency Ablation of the Atrioventricular Node
-
Reliability of Doppler Echo for Valvular Regurgitation
-
Predictive Value of Coronary Pressure Measurements After Stenting
-
Prevention of Postoperative Atrial Fibrillation
-
The Best Stent for Saphenous Vein Grafts Is?
After 8-10 years, atherosclerosis of saphenous vein grafts and symptoms of ischemia are common. Since repeat bypass surgery is associated with a higher mortality than first surgeries, percutaneous interventions (PCI) are preferred for vein graft disease. -
Do All Brugada Patients Need an ICD?
Sacher and colleagues collected data on all patients diagnosed with Brugada syndrome who received an implantable cardioverter defibrillator (ICD) in 14 centers between 1993 and 2005. -
Can Chemotherapy Cardiotoxicity Be Prevented?
The cardiotoxicity of anthracyclines and other agents may negatively affect clinical outcomes in cancer survivors. Data in other clinical situations and animal data on anthracycline-induced cardiomyopathy suggests that angiotensin-converting enzyme inhibitors (ACEI) may ameliorate this cardiotoxicity.